• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 6 of 6

  • Page:
  • 1
  • 2

No Association Between Decreases in Serum Immunoglobulin (Ig) Levels Below Lower Limit of Normal (LLN) and Serious Infections (SI) with Long-term Ublituximab (UBL) Treatment in Patients with Relapsing Multiple Sclerosis (RMS)

Author:Steinman, Lawrence   Fox, Edward   Hartung, Hans-Peter   Alvarez, Enrique   Qian, Peiqing   Wray, Sibyl   Robertson, Derrick   Selmaj, Krzysztof   Wynn, Daniel   Mok, Koby   Hsu, Yanzhi   Xu, Yihuan   Rowland, Chris   Bodhinathan, Karthik   Sportelli, Peter   Parker, Jackie   Miskin, Ha   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.017  

Author Institution:Stanford Medicine, Stanford, CA  TG Therapeutics, Morrisville, NC  Heinrich Heine University Medical Faculty, Dusseldorf, Germany  University of Colorado, Aurora, CO  Swedish Medical Center, Seattle, WA  Hope Neurology, Knoxville, TN  University of South Florida, Tampa, FL  University of Warmia and Mazury, Lodz, Poland  Consultants in Neurology, Ltd., Northbrook, IL  TG Therapeutics, Oviedo, FL  TG Therapeutics, Lexington, MA  TG Therapeutics, New York, NY  UCSF, Multiple Sclerosis Center, San Francisco, CA  

  • View Abstract
  • View Disclosure

Displaying 6 - 6 of 6

  • Page:
  • 1
  • 2

© 2015 Mira Smart Conference | http://www.mirasmart.com